CD274 and head and neck squamous cell carcinoma: For HNSCC, mPDCD1 as a surrogate marker for immune cell infiltration may be of special value, since differential PD-L1 expression has failed to discriminate between patients prone to therapy failure and those with a reasonable response to [12, 28].